Edwin Jonathan Tucker - 07 Jun 2024 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Reporting relationship: Chief Medical Officer
Issuer ticker: JSPR
Reported as of: 07 Jun 2024
Net transaction value: +$1,669
SEC form: 4
Accepted by SEC: 10 Jun 2024, 18:31:44 UTC
Prior SEC filing: 20 Feb 2024
Next SEC filing: 18 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Herb Cross, as Attorney-in-Fact

Key filing fact

Edwin Jonathan Tucker filed Form 4 for Jasper Therapeutics, Inc. (JSPR) on 10 Jun 2024.

Key facts

This page summarizes Edwin Jonathan Tucker's Form 4 filing for Jasper Therapeutics, Inc. (JSPR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jun 2024, 18:31.

Change

Previous filing in this sequence was filed on 20 Feb 2024.
Current net transaction value: +$1,669.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JSPR transaction

Voting Common Stock

Award

Transaction value: $1,669
Shares: +400
Change %
Price: $4.17
Shares after: 400
Date: 07 Jun 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC remarks

Exhibit 24 - Power of Attorney